Brief: Agile Therapeutics - Set Up Wholesale Acquisition Cost Of $159.75 For Treatment Cycle Of Twirla Transdermal System
30/06/2020 11:37
June 30 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS - ON JUNE 26, CO ESTABLISHED A
WHOLESALE
ACQUISITION COST OF $159.75 FOR A TREATMENT CYCLE OF ITS TWIRLA
TRANSDERMAL SYSTEM.
* AGILE THERAPEUTICS - EACH TWIRLA TREATMENT CYCLE IS
PACKAGED IN
A CARTON CONTAINING 3 INDIVIDUALLY POUCHED TRANSDERMAL SYSTEMS
Source text for Eikon: https://bit.ly/3if77Sz
Further company coverage: AGRX.O
((Briefs@thomsonreuters.com;))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt